In Brief
Recognition of viral RNA by RIG-I-like receptors (RLRs) initiates innate antiviral response. Lian et al. demonstrate that ZCCHC3 is a co-receptor for RLRs, thereby acting as an important modulator of innate antiviral response.
INTRODUCTION
The innate immune system is the first line of host defense against microbial infection. Upon infection, the conserved microbial components called pathogen-associated molecular patterns (PAMPs) are sensed by cellular pattern recognition receptors (PRRs), which trigger signaling leading to the induction of type I interferons (IFNs), pro-inflammatory cytokines, and other downstream effector genes. These downstream effector proteins mediate innate immune and inflammatory responses by inhibiting microbial replication and promoting clearance of infected cells, thereby facilitating the host adaptive immune response to eliminate infected pathogens G€ urtler and Bowie, 2013; Hiscott, 2007; Medzhitov, 2007) .
Viral nucleic acids are major PAMPs that are sensed by the host cells after viral infection. Extracellular viral RNA is recognized by transmembrane and endosomal Toll-like receptor 3 (TLR3), which is expressed mostly in immune cells, whereas intracellular viral RNA is detected by the retinoic acid-inducible gene-I (RIG-I)-like receptors (RLRs), including RIG-I and MDA5, which are lowly expressed in most cell types and induced after viral infection. Genetic studies have demonstrated that RIG-I and MDA5 play crucial roles in innate immune response to different types of RNA viruses Yoneyama and Fujita, 2009; Yoneyama et al., 2004) .
RIG-I and MDA5 are structurally related: both contain two N-terminal tandem caspase activation and recruitment domains (CARDs), a middle helicase domain, and a C-terminal domain (CTD) (Saito et al., 2007) . The CTDs of RIG-I and MDA5 are structurally divergent, which dictates their abilities to sense distinct viral RNAs. It has been demonstrated that RIG-I preferably recognizes viral 5 0 -ppp double-strand (ds) RNA and short dsRNA, while MDA5 has higher affinity to long dsRNA (Hornung et al., 2006; Kato et al., 2006 Kato et al., , 2008 . Various studies have shown that RIG-I is responsible for sensing infection of Sendai virus (SeV), vesicular stomatitis virus (VSV), Newcastle disease virus (NDV), and influenza virus, while MDA5 appears to mostly detect infection of picornaviruses, such as encephalomyocarditis virus (EMCV) (Kato et al., , 2008 . Infection of some RNA viruses, such as Dengue virus (DEN) and SeV, can be sensed by both RIG-I and MDA5 (Diao et al., 2007; Loo et al., 2008) .
RIG-I and MDA5 utilize similar signaling pathways to induce downstream antiviral genes. Upon binding to viral RNA, RIG-I and MDA5 are recruited to the mitochondrion-located adaptor protein VISA (also known as MAVS, CARDIF, and IPS-1) (Seth et al., 2005; Xu et al., 2005) . VISA then acts as a central platform for recruitment of downstream signaling components such as WDR5, cIAP1/2, TRAF2, 3, and 6, GSK3b, TBK1, and IKK, leading to activation of the kinases TBK1 and IKK. These kinases further phosphorylate the transcription factor IRF3 and the inhibitor of NF-kB (IkBa), leading to activation of IRF3 and NF-kB and eventual induction of downstream antiviral genes (Hou et al., 2011; Lei et al., 2010; Mao et al., 2010; McWhirter et al., 2005) .
Activation of RIG-I and MDA5 is regulated by a series of post-translational modifications, such as polyubiquitination, sumoylation, and phosphorylation Liu et al., 2016; Wallach and Kovalenko, 2013) . The polyubiquitination of RIG-I and MDA5 plays an essential role in the regulation of their activities. It has been shown that the E3 ubiquitin ligases TRIM25, TRIM4, and Riplet (also known as RNF135) are required for activation of RIG-I by catalyzing its K63-linked polyubiquitination in the CARDs and CTD, respectively (Gack et al., 2007; Oshiumi et al., 2009; Yan et al., 2014) . The E3 ubiquitin ligase TRIM65 is important for activation of MDA5 by catalyzing its K63-linked polyubiquitination in the helicase domain (Lang et al., 2017) . In a cell-free system, unanchored K63-linked polyubiquitin chains can bind to the CARDs of both RIG-I and MDA5, which is important for their activation (Jiang et al., 2012) . Whether the CARDs of RIG-I and MDA5 are similarly or distinctly regulated by K63-linked polyubiquitination is enigmatic. Most importantly, because RIG-I and MDA5 are lowly expressed in un-infected cells, whether and how the binding of viral RNA to RIG-I and MDA5 is regulated for efficient sensing of viral RNA remains elusive. In this study, we identified ZCCHC3 as an important regulator of RIG-I-and MDA5-mediated signaling pathways. ZCCHC3 deficiency inhibited RNA virus-induced transcription of downstream antiviral genes and innate antiviral response in mice. Mechanistically, ZCCHC3 bound to viral RNA, interacted with RIG-I and MDA5, and promoted their binding to viral RNA. ZCCHC3 was also important for TRIM25-mediated K63-linked polyubiquitination and activation of RIG-I and MDA5. Our findings suggest that ZCCHC3 acts as a co-receptor for RIG-I and MDA5, which promotes their activation by two distinct mechanisms.
RESULTS

ZCCHC3
Positively Regulates Viral RNA-Triggered Signaling To identify candidate molecules involved in viral RNA-triggered innate immune response, we screened $10,000 independent human cDNA clones for their abilities to regulate interferon-stimulated response element (ISRE) activity by reporter assays and identified ZCCHC3 as a candidate protein. As shown in Figure 1A , overexpression of ZCCHC3 activated the IFN-b promoter (which is driven by ISRE and kB enhancers) and potentiated SeV-triggered activation of the IFN-b promoter in a dose-dependent manner. In addition, overexpression of ZCCHC3 activated ISRE and NF-kB and potentiated SeV-induced ISRE and NF-kB activation ( Figure 1B ). Quantitative PCR (qPCR) experiments indicated that overexpression of ZCCHC3 potentiated SeV-induced transcription of downstream genes including IFNB1, ISG56, CXCL10, and TNFa ( Figure S1A ). These results suggest that ZCCHC3 is involved in RNA virus-triggered induction of downstream antiviral genes.
We next determined whether endogenous ZCCHC3 is required for RNA virus-triggered signaling. We generated ZCCHC3-deficient HEK293 and THP1 cells by CRISPR-Cas9. The transcription of downstream genes such as IFNB1, ISG56, and CXCL10 induced by SeV or VSV was markedly inhibited in two independent ZCCHC3-deficient HEK293 clones compared with control cells ( Figure 1C) . Consistently, the transcription of IFNB1 induced by cytoplasmic transfected either high-or low-molecular-weight (HMW or LMW) poly(I:C) was markedly inhibited in ZCCHC3-deficient HEK293 cells ( Figure 1D ). In addition, phosphorylation of TBK1, IRF3, and IkBa induced by SeV in ZCCHC3-deficient HEK293 cells was markedly decreased in comparison with control cells ( Figure 1E ). Similarly, transcription of downstream genes and phosphorylation of TBK1, IRF3, and IkBa induced by VSV and EMCV infection was markedly inhibited in ZCCHC3-deficient THP1 cells in comparison to control cells ( Figures S1B and S1C ). In contrast, IFN-g-induced transcription of IRF1 ( Figure 1F ) and phosphorylation of STAT1 at Y701 ( Figure 1G ) was comparable between ZCCHC3-deficient and control cells. These results suggest that ZCCHC3 is required for RNA virus-triggered signaling in different types of cells.
To further confirm the functions of ZCCHC3 in RNA virus-triggered signaling, we constructed four human ZCCHC3-RNAi plasmids that could knock down the levels of endogenous ZCCHC3 to various degrees ( Figure S2A ). Reporter assays indicated that knockdown of ZCCHC3 inhibited SeV-induced activation of the IFN-b promoter, ISRE, and NF-kB ( Figure S2B ), suggesting that ZCCHC3 is involved in both SeV-induced IRF3 and NF-kB activation pathways. Knockdown of ZCCHC3 also inhibited activation of the IFN-b promoter triggered by cytoplasmic transfection of the dsRNA analog poly(I:C) ( Figure S2C ). Consistently, knockdown of ZCCHC3 significantly inhibited SeV-induced transcription of downstream genes such as IFNB1, ISG56, CXCL10, and TNFa ( Figure S2D ). In these experiments, the effects of the RNAi plasmids were correlated to their knockdown efficiencies. In addition, phosphorylation of TBK1, IRF3, and IkBa after SeV infection, which are hallmarks of their activation, was markedly inhibited by ZCCHC3 knockdown in HEK293 cells ( Figure S2E ). These results further confirm that ZCCHC3 is an important mediator of RLR-mediated signaling pathways.
ZCCHC3 Deficiency Inhibits Viral RNA-Triggered Signaling
To further investigate the roles of ZCCHC3 in vivo, we generated Zcchc3-deficient mice. Immunoblot analysis confirmed that Zcchc3 protein was deficient in Zcchc3 À/À mouse lung fibroblasts (MLFs) ( Figure S3A ). Homozygous Zcchc3 À/À mice were born at the Mendelian ratio ( Figure S3B ). In addition, the cellular compositions in the spleen, lymph nodes, and thymus were normal in the Zcchc3 À/À mice ( Figure S3C ). These data suggest (Figure 2A ), BMDCs ( Figure S4A ), and MLFs ( Figure S4B ). Zcchc3 deficiency also decreased the levels of secreted IFN-b and IL-6 induced by VSV or EMCV in BMDCs ( Figure S4C ). In addition, transcription of downstream genes induced by transfected 5 0 ppp-dsRNA, EMCV-or SeV-derived RNA, poly(I:C)-HMW, and poly(I:C)-LMW was inhibited in Zcchc3 À/À in comparison to wild-type MLFs ( Figure 2B ). Consistently, the phosphorylation of Tbk1, Irf3, and IkBa induced by SeV and EMCV was markedly inhibited in Zcchc3 À/À in comparison to wild-type BMDCs ( Figure 2C ). In contrast, transcription of Irf1, Gbp1, and Cxcl10 triggered by IFN-g was comparable between Zcchc3 À/À and Zcchc3 +/+ BMDCs ( Figure S4D ). These data suggest that Zcchc3 is required for efficient induction of downstream antiviral genes by different types of RNA viruses in primary mouse immune cells and fibroblasts.
Zcchc3 Is Essential for Innate Antiviral Response In Vivo
To evaluate the importance of Zcchc3 in host defense against viral infection in vivo, we intra-nasally infected 8-week-old À/À mice were significantly more susceptible to VSVand EMCV-induced death ( Figure 3A ). Consistently, sera from Zcchc3 À/À mice infected with VSV or EMCV for 6 hr showed significantly lower amounts of IFN-b, IL-6, CXCL10, and TNFa compared with that of wild-type mice ( Figure 3B ). Additionally, the amounts of genomic copies and viral titers of VSV in the spleen or EMCV in the brains were much higher in Zcchc3 À/À mice at 2 days after viral infection ( Figure 3C ). These results suggest that Zcchc3 is important in host defense against RNA viruses in vivo.
ZCCHC3 Interacts with RIG-I and MDA5
To determine the mechanisms of how ZCCHC3 functions in innate antiviral response, we first investigated cellular localization of ZCCHC3 before and after viral infection. Cell fractionation experiments indicated that ZCCHC3 was distributed in the cytoplasm before or after SeV infection ( Figure S5A ). We then examined the effects of ZCCHC3 deficiency on activation of ISRE mediated by overexpression of various components in the RLR-mediated pathways. The results indicated that ZCCHC3 deficiency inhibited RIG-I-, RIG-I-CARD-, MDA5-, and MDA5-CARD-but not VISA-, TBK1-, or IRF3-5D-mediated activation of ISRE ( Figure S5B ). These results suggest that ZCCHC3 functions at the RIG-I or MDA5 level. Co-immunoprecipitation experiments indicated that ZCCHC3 was associated with RIG-I and MDA5 but not VISA, TBK1, or IRF3 in mammalian overexpression system ( Figure S5C ). Furthermore, endogenous ZCCHC3 was constitutively associated with low amounts of RIG-I and MDA5 in un-infected cells and these associations were increased after SeV or EMCV infection, respectively. In the same experiments, ZCCHC3 was not associated with ISG56 after SeV infection ( Figure 4A ). Both RIG-I and MDA5 contain two N-terminal CARD domains, a middle helicase domain, and a CTD, whereas ZCCHC3 contains an N-terminal (aa1-300) and three tandem zinc finger (ZF) domains (aa300-404) at its C terminus (Figure S5D) . Domain mapping experiments indicated that the CARD and helicase domains of RIG-I or MDA5 could independently interact with the N terminus of ZCCHC3 ( Figure S5D ). Reporter assays indicated that the truncations of ZCCHC3 that could interact with RIG-I and MDA5 also potentiated RIG-I-CARD-or MDA5-CARD-mediated activation of the IFN-b promoter, whereas the ZCCHC3(300-404) truncation, which lost its ability to interact with RIG-I and MDA5, inhibited RIG-I-CARD-or MDA5-CARDmediated activation of the IFN-b promoter ( Figure S6A ). These results suggest that ZCCHC3 is associated with RIG-I and MDA5 and that these associations are necessary for the functions of ZCCHC3 in RIG-I-and MDA5-mediated signaling.
ZCCHC3 Binds to Viral RNA and Mediates Sensing of Viral RNA by RIG-I and MDA5
Since ZCCHC3 is a CCHC-type zinc finger protein that is predicted to bind to RNA, we determined whether ZCCHC3 binds to viral RNA similarly as RIG-I and MDA5. Previously, it has been shown that the CTD of RIG-I binds to 5 0 ppp-ssRNA, 5 0 ppp-dsRNA, and short blunt-ended dsRNA, with significantly higher affinity for 5 0 ppp-dsRNA (Lu et al., 2010; Takahasi et al., 2008) , whereas the CTD of MDA5 has high affinity to long dsRNA such as synthetic poly(I:C) (Li et al., 2009) . Pull-down experiments indicated that ectopically expressed ZCCHC3 could bind to 5 0 ppp-dsRNA and poly(I:C) ( Figure 4B ). In these experiments, ZCCHC3 also enhanced the binding of RIG-I to 5 0 pppdsRNA and MDA5 to poly(I:C), respectively ( Figure 4B ), whereas ZCCHC3 deficiency in the cell had the opposite effects (Figure 4C ). Deletion analysis indicated that the three ZFs could independently bind to 5 0 ppp-dsRNA and poly(I:C) ( Figure S6B ). The truncations of ZCCHC3 that could bind to 5 0 ppp-dsRNA and poly(I:C) also enhanced the binding of RIG-I to 5 0 ppp-dsRNA and MDA5 to poly(I:C), respectively ( Figure S6C ). We have further produced recombinant ZCCHC3 and MDA5 (280-1,025) (we have not been able to produce active RIG-I so far) and in vitro pull-down analysis confirmed that recombinant ZCCHC3 increased the binding of MDA5 (280-1,025) to poly(I:C) ( Figure 4D ). Microscale thermophoresis technology (MST) experiments indicated that ZCCHC3 could bind to dsRNA (25 bp) with an affinity of Kd = 40 ± 0.786 nM, which was slightly higher than that of MDA5 with dsRNA (Kd = 81.9 ± 4.31 nM). In addition, recombinant ZCCHC3 bound to MDA5 (280-1,025) to a similar degree with Kd = 182 ± 64.4 nM ( Figure 4E ). Collectively, these results suggest that ZCCHC3 acts as a co-receptor for RIG-I and MDA5 and promotes their binding to RNA.
To determine whether the ZFs of ZCCHC3 have similar functions as the CTDs of RIG-I and MDA5, we replaced the CTDs of RIG-I and MDA5 with the ZFs of ZCCHC3 and examined the abilities of the chimeric molecules (RIG-I/ZCCHC3 and MDA5/ ZCCHC3) to respond to RNA stimulation. We found that RIG-IDCTD and MDA5DCTD, which lack their respective C-terminal repressor domain (Saito et al., 2007) , activated the IFN-b promoter but failed to respond to stimulation by their ligands 5 0 ppp-dsRNA and EMCV RNA, respectively. In contrast, though RIG-I-ZCCHC3 and MDA5-ZCCHC3 only weakly activated the IFN-b promoter, they responded well to 5 0 ppp-dsRNA and poly(I:C), respectively ( Figure 4F ). These results suggest that the ZFs of ZCCHC3 can respond to viral RNA stimulation similarly as the helicase and CTD of RLRs.
We lastly examined whether ZCCHC3 binds to viral RNA in infected cells by ''footprint'' experiments. After SeV infection (which is recognized by both RIG-I and MDA5), we immunoprecipitated RIG-I, MDA5, cGAS, and ZCCHC3 and the immunoprecipitates were treated with RNase I. The protein-protected viral RNA was detected by RT-PCR with primers targeting various regions of SeV RNA. As shown in Figure 4G , ZCCHC3, RIG-I, and MDA5 could bind to overlapping regions of SeV RNA but not cGAS (Figure 4G) . These experiments suggest that ZCCHC3 can bind to naturally infected viral RNA, which is consistent with its role as a co-receptor.
ZCCHC3 Promotes K63-Linked Polyubiquitination of RIG-I and MDA5 by TRIM25
It has been previously shown that K63-linked polyubiquitination of the CARDs of RIG-I by TRIM25 is essential for its activation (Gack et al., 2007) . As shown above, ZCCHC3 interacted with the CARDs of RIG-I and MDA5 ( Figure S5D ) and promoted RIG-I-CARD-and MDA5-CARD-mediated signaling ( Figure S6A ). ) were transfected with the indicated plasmids (5 mg each). At 20 hr after transfection, cells were infected with SeV for 3 hr. Cell lysates were then immunoprecipitated with control IgG or anti-HA. The immunoprecipitates were treated with RNAase I and bound-RNA was extracted for qPCR analysis. Other examined regions of the SeV RNAs that were not bound by the proteins were not presented. *p < 0.05, **p < 0.01 (unpaired t test). Data are representative of at least two experiments with similar results (mean ± SD, n = 3 independent samples in F and G). See also Figures S5 and S6 .
In addition, ZCCHC3 (300-404) did not interact with RIG-I and MDA5 but inhibited RIG-I-CARD-and MDA5-CARD-mediated signaling ( Figure S6A ). These results suggest that ZCCHC3 has an additional mechanism to regulate RLR-mediated signaling in addition to its ability to promote the RNA binding of RLRs. Co-immunoprecipitation experiments indicated that overexpression of ZCCHC3 markedly increased K63-but not K48-linked or other lysine residue-linked polyubiquitination of RIG-I-CARD and MDA5-CARD ( Figure 5A ), whereas ZCCHC3 deficiency markedly decreased SeV-or EMCV-induced K63-linked polyubiquitination of RIG-I-CARD and MDA5-CARD, respectively ( Figure 5B ). In these experiments, ZCCHC3 deficiency had no effects on SeV-or EMCV-induced K48-linked polyubiquitination of RIG-I-CARD and MDA5-CARD ( Figure 5C ). These data suggest that ZCCHC3 specifically promotes K63-linked polyubiquitination of the CARDs of RIG-I and MDA5. Previous studies have identified three E3 ubiquitin ligases, including TRIM25, TRIM4, and Riplet/RNF135, that can mediate K63-linked polyubiquitination of RIG-I (Gack et al., 2007; Oshiumi et al., 2009; Yan et al., 2014) . In cell-free system, unanchored K63-linked polyubiquitin chains can bind to the CARDs of RIG-I and MDA5 to promote their activation (Jiang et al., 2012) . Whether and how the CARDs of MDA5 are modified by K63-linked polyubiquitination was enigmatic. We further determined how ZCCHC3 affects K63-linked polyubiquitination and activation of RIG-I and MDA5. Co-immunoprecipitation experiments indicated that ZCCHC3 was specifically associated with TRIM25 but not TRIM4, RNF135, and TRIM65 in mammalian overexpression system ( Figure 6A ). Endogenous ZCCHC3 was constitutively associated with TRIM25 in un-infected cells, and this association was increased after SeV infection ( Figure 6B ). Domain mapping experiments indicated that the C-terminal ZFs of ZCCHC3 and the C-terminal SPRY domain of TRIM25 were required for their interaction ( Figure S7A ).
Ubiquitination assays indicated that TRIM25 markedly enhanced K63-linked polyubiquitination of RIG-I, MDA5, and MDA5-CARD ( Figure S7B ). Previously, it has been shown that TRIM25 mediates K63-linked polyubiquitination of the CARDs of RIG-I but not MDA5 (Gack et al., 2007) . We believe that these contradictory conclusions are caused by the epitope tagging of TRIM25. The previous study (Gack et al., 2007) used a V5-tagged TRIM25 for their ubiquitination assays, and we found that untagged but not HA-tagged TRIM25 could increase the K63-linked polyubiquitination of MDA5 ( Figure S7B ). Consistently, knockdown of TRIM25 markedly inhibited EMCV-induced K63-linked polyubiquitination of MDA5-CARD ( Figure S7C ). qPCR analysis showed that knockdown of TRIM25 dramatically inhibited VSV-or EMCV-induced transcription of downstream genes ( Figure S7D ). In addition, overexpression of TRIM25 promoted RIG-I-CARD-and MDA5-CARD-mediated activation of the IFN-b promoter in a dose-dependent manner ( Figure S7E ), whereas TRIM25 deficiency markedly inhibited RIG-I-CARDand MDA5-CARD-mediated activation of the IFN-b promoter (Figure S7F) . These results suggest that TRIM25 mediates K63-linked polyubiquitination and activation of both RIG-I and MDA5.
We next investigated whether ZCCHC3 plays a role in K63-linked polyubiquitination of RIG-I and MDA5 mediated by TRIM25. Co-immunoprecipitation experiments indicated that ZCCHC3 promoted the association of TRIM25 with RIG-I and MDA5 ( Figure 6C ), whereas their associations were decreased in ZCCHC3-deficient cells ( Figure 6D) . It has been shown that K63-linked polyubiquitination of RIG-I is essential for their recruitment to VISA (Gack et al., 2007) . We found that ZCCHC3 deficiency markedly inhibited the association of VISA with RIG-I and MDA5 ( Figure 6E ). Consistently, ZCCHC3 synergized with TRIM25 and RIG-I-CARD or MDA5-CARD in activating the IFN-b promoter in a dose-dependent manner ( Figure 6F ), while ZCCHC3 deficiency markedly inhibited the collaborative activation of the IFN-b promoter by TRIM25 and RIG-I-CARD or MDA5-CARD ( Figure 6G ). In addition, co-immunoprecipitation experiments indicated that overexpression of ZCCHC3 had no effects on polyubiquitination of RIG-I-CARD and MDA5-CARD in TRIM25-deficient cells ( Figure 7A ). Consistently, TRIM25 deficiency inhibited ZCCHC3-mediated activation of the IFN-b promoter ( Figure 7B ) as well as induction of IFNB1, CXCL10, and TNFa ( Figure 7C ). Collectively, these results suggest that ZCCHC3 mediates K63-linked polyubiquitination and activation of RIG-I and MDA5 by TRIM25.
DISCUSSION
In this study, we investigated the roles of ZCCHC3 in RIG-Iand MDA5-mediated signaling. Overexpression of ZCCHC3 significantly potentiated SeV-induced activation of ISRE, NF-kB, and the IFN-b promoter, whereas knockdown of ZCCHC3 had the opposite effects. Gene knockout in mice suggests that ZCCHC3 deficiency inhibits RNA virus-induced transcription of downstream antiviral genes in various fibroblasts and immune cells and renders the mice more susceptible to VSV-and EMCV-induced death. These findings establish a critical role for ZCCHC3 in innate immune response to RNA virus. Interestingly, we also found that ZCCHC3 plays important roles in cGAS-mediated innate immune responses (data not shown).
Our results suggest that ZCCHC3 acts as a co-receptor for RLR binding to RNA. Co-immunoprecipitation experiments indicated that ZCCHC3 was associated with RIG-I and MDA5 in uninfected cells and that their associations were increased after RNA virus infection. ZCCHC3 can bind to dsRNA by itself through its ZFs and promotes the binding of RIG-I and MDA5 to dsRNA. In vitro biochemical experiments with recombinant proteins indicated that ZCCHC3 bound to dsRNA with slightly higher affinity than MDA5, and ZCCHC3 also bound to MDA5. Footprint assays indicated that ZCCHC3 bound to SeV RNA with less specificity than RIG-I and MDA5, suggesting that ZCCHC3 facilitates the sensing of distinct viral RNA by RIG-I and MDA5, which is consistent with its role as a co-sensor of the RLRs. Consistently, ZCCHC3 deficiency inhibited the binding of RIG-I and MDA5 to dsRNA as well as their recruitment to downstream adaptor protein VISA. Deletion of the CTDs of RIG-I and MDA5 abolished their abilities to signal IFN-b promoter activation induced by RNA stimulation, whereas replacement of the CTDs of RIG-I and MDA5 with the ZFs of ZCCHC3 restores their abilities to potentiate RNA-stimulated activation of the IFN-b promoter. Functionally, deficiency of ZCCHC3 inhibits RIG-I-and MDA5-mediated signaling. These results collectively suggest that ZCCHC3 is an essential co-receptor for RIG-I-and MDA5-mediated innate responses to viral RNA.
In addition to acting as a co-receptor for ligand binding of RIG-I and MDA5, ZCCHC3 also mediates K63-linked polyubiquitination and activation of RIG-I and MDA5. Previously, it has been shown that TRIM25-mediated K63-linked polyubiquitination of RIG-I-CARD is essential for its activation (Gack et al., 2007) . However, whether MDA5 is also regulated by TRIM25 is controversial (Gack et al., 2007; Jiang et al., 2012) . In this study, we found that TRIM25 could catalyze K63-mediated polyubiquitination of MDA5-CARD in a way similar to RIG-I-CARD. ZCCHC3 deficiency inhibited K63-linked polyubiquitination of RIG-I-CARD induced by SeV as well as K63-linked polyubiquitination of MDA5-CARD induced by EMCV, which triggers MDA5-mediated signaling. ZCCHC3 was associated with TRIM25 and this association was increased after viral infection. Overexpression of ZCCHC3 increased the association of TRIM25 with RIG-I and MDA5. Functionally, ZCCHC3 potentiated activation of the IFN-b promoter by TRIM25 and RIG-I-CARD or MDA5-CARD, whereas ZCCHC3 deficiency had the opposite effects. These results suggest that ZCCHC3 mediates K63-linked polyubiquitination and activation of RIG-I and MDA5 by TRIM25. In our experiments, we found that ZCCHC3 deficiency did not completely abolish RIG-I-CARD-and MDA5-CARD-mediated activation of the IFN-b promoter. There are several possibilities that can account for these observations. First, deficiency of TRIM25 itself does not completely abolish virus-triggered induction of downstream antiviral genes. Second, another protein plays a redundant role in mediating the association of RIG-I/MDA5 with TRIM25. Third, TRIM25 itself can be recruited to RIG-I/ MDA5 with low affinity, and ZCCHC3 acts as a modulator to increase the recruitment of TRIM25 to RIG-I and MDA5.
Domain mapping experiments indicated that the N terminus of ZCCHC3 is responsible for interaction with the helicase and CARDs of RIG-I/MDA5, while the C-terminal ZFs of ZCCHC3 binds to dsRNA and promote the binding of dsRNA to the CTD of RIG-I/MDA5. The C-terminal ZFs of ZCCHC3 also binds to the C-terminal SPRY domain of TRIM25, which may promote the interaction of the SPRY domain of TRIM25 with the CARDs of RIG-I/MDA5. Therefore, ZCCHC3 may utilize its N terminus to anchor it to RIG-I/MDA5 and utilize its C-terminal ZFs to facilitate dsRNA and TRIM25 binding to the CTD and CARDs of RIG-I/MDA5, respectively, leading to K63-linked polyubiquitination of the CARDs of RLRs and their activation.
In conclusion, our study identified ZCCHC3 as a critical component of innate antiviral response mediated by RLRs. ZCCHC3 acts as a co-receptor which promotes viral RNA binding to the RLRs as well as their K63-linked polyubiquitination and activation by TRIM25. Previously, it has been demonstrated that CD14 and Mex3B act as co-receptors for Toll-like receptor 4 and 3, respectively (Wright et al., 1990; Yang et al., 2016) . These studies suggest that utilization of co-receptors may be a general strategy for innate immune responses mediated by PRRs.
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Quantitative real-time PCR Total RNA was isolated for qPCR analysis to measure mRNA abundance of the indicated genes (See Table S1 ). Data shown are the relative abundance of the indicated mRNAs normalized to that of GAPDH mRNA.
Co-immunoprecipitation, ubiquitination and immunoblotting analysis Co-immunoprecipitation, ubiquitination and immunoblotting were performed as previously described Wei et al., 2015; Zhong et al., 2008; Zhou et al., 2014) . Cells were lysed in NP-40 lysis buffer. For ubiquitination assays, the immunoprecipitates were re-extracted in NP-40 lysis buffer containing 1% SDS and denatured by heating for 5 min. The supernatants were diluted with regular lysis buffer until the concentration of SDS was decreased to 0.1%, following by re-immunoprecipitation with the indicated antibodies, and the immunoprecipitates were analyzed by immunoblotting with the ubiquitin antibody.
Subcellular fractionation
Cell fractionation assays were performed as previously described . In brief, HEK293 cells infected with SeV or left uninfected, and cells were lysed by douncing 25 times in 1 mL CER. The homogenates were centrifuged twice at 500 g for 5 min to precipitate cytosol. The pellets were washed with NER and centrifuged twice at 4000 g for 5 min to precipitate nucleus. The nucleus fractions were lysed in NP-40 lysis buffer for immunoblotting analysis.
In vitro pull-down assays Poly(I:C) and 5 0 ppp-dsRNA was conjugated with biotin by UV (365 nm wave-length) cross-linking for 45 min. HEK293 cells transfected with the indicated plasmids were lysed in NP-40 lysis buffer. Lysates were incubated with biotinylated-5 0 ppp-dsRNA or biotinylated-poly(I:C) for 1 hour at 4 C, and then incubated with streptavidin beads for another 2 hours at 4 C. The beads were washed three times with lysis buffer and analyzed by immunoblot with the indicated antibodies.
Preparations of BMDMs, BMDCs and MLFs
For preparation of BMDMs, the bone marrow cells were cultured in 10% M-CSF-containing conditional medium from L929 cells for 3-5 days. For preparation of BMDCs, the bone marrow cells were cultured in medium containing murine GM-CSF (50 ng/mL) for 6-8 days. Primary lung fibroblasts were isolated from lungs of 8-week old mice as previously described . In brief, lungs were minced and digested in calcium and magnesium free HBSS containing 10 mg/mL type II collagenase and 20 mg/mL DNase I for 1 hour at 37 C with shaking. Cell suspension was centrifuged at 1500 rpm for 5 min. The cells were then plated in culture medium (1:1 [v/v] DMEM/Ham's F-12 containing 10% FBS, 50 U/mL penicillin, 50 mg/mL streptomycin, 15 mM HEPES, 2 mM L-glutamine).
ELISA BMDCs were stimulated with viruses for 18 hours and eight-week old Zcchc3 +/+ and Zcchc3 À/À mice were intra-nasally infected with viruses for 6 hours. The culture media and the serum were collected for measurement of IFN-b, IL-6, CXCL10 and TNFa.
Recombinant protein purification
The pGEX-6p-1-GST plasmids encoding ZCCHC3 and MDA5 (280-1025) were transformed into BL21 competent cells. Expression of the proteins was induced with 0.1 mM IPTG at 16 C for 24 hours. The proteins were purified with GST resins and eluted with elution buffer (PBS, 100 mM Tris-HCl pH 8.8, 40mM reduced glutathione).
Microscale thermophoresis technology (MST)
MST analysis was performed using a NanoTemper Monolith NT.115 instrument (NanoTemper Technologies GmbH). For detecting affinity between GST-ZCCHC3 or GST-MDA5 and dsRNA, 20 nM Cy5-labeled 25 bp dsRNA (Sangon Biotech, China) was mixed with different concentrations of proteins in PBS with 100 mM Tris-HCl, pH 8.8. For detecting affinity between GST-ZCCHC3 and GST-MDA5, GST-ZCCHC3 was fluorescently labeled with a Blue-NHS labeling kit according to the manufacturer's instructions. Lysine residues of GST-ZCCHC3 were labeled with a dye: protein molar ratio of 3. GST was used as negative control. Samples were loaded into Premium Coated Capillaries and MST measurements were performed using 20% MST power and 40% LED power at 25 C. Laser-on and -off times were 30 and 5 s respectively. NanoTemper Analysis 1.2.20 software was used to fit the data and to determine the apparent Kd values.
RNA-binding protein immunoprecipitation (RIP)
HEK293 cells were transfected with the indicated HA-tagged plasmids for 20 hours, then infected with SeV for 1 hour, washed with medium and cultured for 2 more hours. Cell lysates were immunoprecipitated with IgG or anti-HA (2 mg) and protein G beads (50 ml) at 4 C for 2 hours. The immunoprecipitates were treated with diluted RNase I (1:25 in PBS) at 37 C for 5 min. The bead-bound immunoprecipitates were washed for 3 times with lysis buffer containing RNase inhibitors. The protein and RNA complexes were eluted with 200 mL TE buffer containing 10 mM DTT at 37 C for 30 min. The RNA was extracted using Trizol reagent before real-time PCR analysis for SeV RNA (See Table S1 ).
Flow cytometry
The spleen, thymus, and peripheral lymph nodes were obtained from Zcchc3 +/+ and Zcchc3 À/À mice, and single-cell suspensions were prepared. After depletion of red blood cells by ammonium chloride, cells were subject to staining with the indicated antibodies for 30 min followed by flow analysis.
QUANTIFICATION AND STATISTICAL ANALYSIS
Unpaired Student's t test was used for statistical analysis with GraphPad Prism Software. For the mouse survival study, Kaplan-Meier survival curves were generated and analyzed by Log-Rank test; p < 0.05 was considered significant.
